Why modern women’s health formulations may require a new generation of Shatavari ingredients.
Shatavari has been used in women’s health formulations for decades, but many products on the market still rely on an older formulation model: high-dose herbal inclusion levels that can require 300–800 mg or more per serving.
That approach is starting to create problems for modern product development.
Today’s brands are being pushed toward cleaner labels, smaller serving sizes, multi-benefit formulas, gummies, stick packs, RTDs, and capsule systems with limited space. Large-dose botanicals can quickly become difficult to work with—especially in women’s health formulas where multiple ingredients are often competing for inclusion.
This is where a new category of Shatavari ingredients is beginning to emerge.
A More Concentrated Approach
Unlike many traditional Shatavari extracts standardized at lower active levels, Xeya Modern Shatavari was developed around a more concentrated formulation strategy.
Xeya Modern Shatvari™ is standardized to 15% shatavarins and clinically studied at just 50–100 mg per day.
That is significantly lower than many conventional Shatavari ingredients currently used in the market. Imagine formulating with 50 mg instead of 800 mg!
For formulators, that creates several immediate advantages:
- More room for complementary actives
- Easier capsule design
- Greater gummy feasibility
- Cleaner supplement facts panels
- Improved formulation flexibility
- Better cost-in-use potential
In practical terms, lower-dose efficiency changes the formulation conversation entirely.
Human Clinical Data Across Multiple Female Life Stages
Another major differentiator is the clinical positioning.
Many Shatavari ingredients rely primarily on traditional Ayurvedic use or generalized women’s wellness positioning. Xeya Modern Shatvari™, however, has human clinical research involving both PCOS-related support and perimenopausal wellness support.
That broader research story gives brands and formulators the ability to explore positioning across multiple stages of women’s health, including:
- Hormonal balance
- Reproductive wellness
- Menstrual comfort
- Perimenopausal support
- Menopausal wellness
- Mood and sleep support
- Skin and hair appearance
- Cycle regularity
This creates a more modern and commercially flexible women’s health platform compared to single-focus botanical positioning.
A Smarter Hormonal Wellness Narrative
Perhaps the most interesting part of the emerging Shatavari conversation is the shift away from simplistic hormone language.
Instead of positioning around “raising hormones,” newer clinical discussions are increasingly centered around supporting hormonal equilibrium and balance across different female populations and life stages. That distinction matters.
Modern consumers are becoming more sophisticated, and brands are looking for ingredient narratives that feel more intelligent, adaptable, and clinically grounded.
This positions concentrated Shatavari ingredients more like modern hormonal adaptogens than traditional herbal commodities.
Why This Matters for Modern Formulation
Women’s health is rapidly evolving into one of the industry’s most competitive innovation categories. At the same time, brands and manufacturers are under pressure to create products that are:
- Clinically credible
- Consumer-relevant
- Lower dose
- Multi-functional
- Delivery-friendly
- Easier to formulate
That environment may favor ingredients designed specifically for modern formulation systems rather than legacy high-dose approaches.
For brands, Xeya Modern Shatvari™ appears to offer a more flexible platform for next-generation women’s health innovation.
For formulators, it may create significantly more room to build smarter multi-active systems.
And for manufacturers, it may represent a differentiated women’s health ingredient worth evaluating and recommending to customers seeking more modern formulation strategies.
Explore Xeya Modern Shatavari™ on NXT Ingredients™ click here.